The Life Sciences Report

Streetwise Reports

Recent Articles

5 Pharma Stocks That Could Double or Triple!

By

Emerging healthcare companies with novel technologies and drugs is where major growth prospects reside.

CANF: Take Multiple Shots on Goal With Can-Fite BioPharma

By

Here's description of Can-Fite BioPharma Ltd (ADR)'s (NYSEMKT:CANF) platform technology and how it can address the different issues of cancer, inflammatory diseases and erectile dysfunction.

Medical Marijuana Goes to Market in Canada

By

In the last nine months, the medical marijuana industry in Canada has experienced a paradigm shift that was years in the making. The Canadian government changed the way it grants and distributes licenses for production of medical Cannabis.

Here’s What to Expect From Australian Biotechs

By

Australian science is strong and a leader in the biotech space. Here's why investors should look to Australia for biotech stocks to buy.

3 Innovative Biotech Stocks to Diversify Your Portfolio

By

Echo Therapeutics (ECTE), Theralase Technologi (TLTFF) and Tribute Pharmaceuticals Canada (TBUFF) are biotech stocks to buy.

Want to Invest in Biotech Stocks? Learn the Rules First.

By

Even in the good conditions of the biotech market today, investors should do due diligence and find reliable sources when picking biotech stocks.

Biotech Stocks With Upside Target Ebola, Liver Disease

By

Developing successful Ebola and liver disease treatments is an incredibly risky opportunity for biotech stocks to create value.